The effects of phospholipid molecular species on cholesterol crystallization in model biles: The influence of phospholipid head groups

Journal of Hepatology

Volumn 28, Issue 6, 1998, Pages 1008-1014

  Ringel, Yehuda ^a   Sömjen, Giora J ^a   Konikoff, Fred M ^a   Rosenberg, Ruth ^a   Michowitz, Moshe ^a   Gilat, Tuvia ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Cholesterol crystallization; Model bile; Phospholipid head groups

Indexed keywords

BILE SALT; CHOLESTEROL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; TAUROCHOLIC ACID;

ARTICLE; BILE; CHOLESTEROL STONE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CRYSTALLIZATION; LIPID COMPOSITION; LIVER TOXICITY; PRIORITY JOURNAL;

EID: 0032101826     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80350-4     Document Type: Article

References (21)

1. Danzinger RG, Hofman AF, Schoenfield LJ, Thistle JL. Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med. 286:1972;1-8.
2. Hofmann AF, Thistle JL, Klein PD, Szczepanik PA, Yu PYS. Chemotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response. JAMA. 239:1978;1138-1144.
3. Jüngst D, Brenner G, Pratschke E, Paumgartner G. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones. J Hepatol. 8:1989;1-6.
4. Loria P, Carulli N, Medici G, Menozzi D, Salvioli G, Bertolotti M, et al. Effect of ursocholic acid on bile lipid secretion and composition. Gastroenterology. 90:1986;865-874.
5. Marcus SN, Heaton KW. Deoxycholic acid and the pathogenesis of gall stones. Gut. 29:1988;522-533.
6. Hofmann AF. Pharmacology of ursodeoxycholic acid, an enterohepatic drug. Scand J Gastroenterol. 29:1994;1-15.
7. Cohen BI, Hofmann AF, Mosbach EH, Stenger RJ, Rotschild MA, Hagey LR, et al. Differing effects of norursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit. Gastroenterology. 91:1986;189-197.
8. Jüngst D, Lang T, Huber P, Lange V, Paumgartner G. Effect of phospholipids and bile acids on cholesterol nucleation time and vesicular/micellar cholesterol in gallbladder bile of patients with cholesterol stones. J Lipid Res. 34:1993;1457-1564.
9. Halpern Z, Moshkowitz M, Laufer H, Peled Y, Gilat T. Effect of phospholipids and their molecular species on cholesterol solubility and nucleation in human and model biles. Gut. 34:1993;110-115.
10. Tao S, Tazuma S, Kajiyama G. Fatty acid composition of lecithin is a key factor in bile metastability in supersatured model bile systems. Biochim Biophys Acta. 167:1993;142-146.
11. Tazuma S, Ochi H, Teramen K, Yamashita Y, Horikawa K, Miura H, et al. Degree of fatty acyl chain unsaturation in biliary lecithin dictates cholesterol nucleation and crystal growth. Biochim Biophys Acta. 1215:1994;74-78.
12. Ringel Y, Sömjen GJ, Konikoff FM, Gilat T. Increased saturation of the fatty acids in the sn-2 position of phospholipids reduces cholesterol crystallization in model biles. Biochim Biophys Acta. 1390:1998;293-300.
13. Pope JL. Crystallization of sodium taurocholate. J Lipid Res. 8:1967;146-147.
14. Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WJ. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology. 77:1979;611-617.
15. Sömjen GJ, Ringel Y, Konikoff FM, Rosenberg R, Gilat T. A new method for the rapid measurement of cholesterol crystallization in model biles using a spectrophotometric microplate reader. J Lipid Res. 38:1997;165-169.
16. Sömjen GJ, Gilat T. A non-micellar mode of cholesterol transport in human bile. FEBS Lett. 156:1983;265-268.
17. Konikoff FM, Laufer H, Messer G, Gilat T. Monitoring cholesterol crystallization from lithogenic model bile by time-lapse density gradient ultracentrifugation. J Hepatol. 26:1997;703-710.
18. Konikoff FM, Carey MC. Cholesterol crystallization from a dilute bile salt-rich model bile. J Crystal Growth. 144:1994;79-86.
19. Groen AK, Noordam C, Drapers JAG, Egbers P, Jansen PLM, Tytgat GNL. Isolation of potent cholesterol nucleating-promoting activity from human gallblader bile: role in the pathogenesis of gallstone disease. Hepatology. 11:1990;525-533.
20. Halpern Z, Lafont H, Arad J, Domingo N, Peled Y, Konikoff FM, et al. The distribution of biliary-anionic polypeptide fraction between cholesterol carriers in bile and its effect on nucleation. J Hepatol. 21:1994;979-983.
21. Konikoff FM, Lechene de la Porte P, Laufer H, Domingo N, Lafont H, et al. Calcium and the anionic polypeptide fraction (APF) have opposing effects on cholesterol crystallization in model bile. J Hepatol. 27:1997;707-715.